Clinical and pharmacogenetic risk factors for the development of early adverse reactions when prescribing antipsychotics for the treatment of conduct disorders in boys without intellectual disability

Frontiers in Psychiatry | New and Recent Articles ·
Mind & Mental Health Switzerland

ObjectivesTo identify associations between the DRD2 rs1800497 and HTR2A rs6311/rs6313 genotypes, adjunctive pharmacotherapy and the effectiveness and safety of antipsychotics prescribed for conduct disorders in boys without intellectual disability in first 14 days of treatment.MethodsThis study included 115 boys aged 7–12 years without intellectual disability hospitalized for conduct disorders…

Read original article on Frontiers in Psychiatry | New and Recent Articles →